Rockwood to sell Groupe Novasep
Chemicals maker Rockwood Holdings plans to sell its Groupe Novasep subsidiary, French provider of synthesis and purification solutions for the life science industries, to a consortium led by Gilde Buyout Partners for approximately Euro 425m.
Chemicals maker Rockwood Holdings plans to sell its Groupe Novasep subsidiary, French provider of synthesis and purification solutions for the life science industries, to a consortium led by Gilde Buyout Partners for approximately Euro 425m.
Groupe Novasep, which is 78.6% owned by Rockwood, will be bought by a consortium of Gilde, Banexi Capital and Groupe Novasep management.
The subsidiary produces active pharmaceutical ingredients, and develops purification processes, and Novasep ceo Roger Marc Nicoud said of the acquisition: 'Rockwood allowed Novasep to grow dramtically in the last two years, and acted as a very responsible and committed partner,' adding that 'our common vision was for our co-operation with Rockwood to be limited in time.'
